DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation CarriersAna Osório, Anne‐Marie Gerdes, Roger L. Milne et al.|PLoS Genetics|2014Cited by 130
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian CancersHuong Meeks, Pascal Guénel, Olivia Fletcher et al.|JNCI Journal of the National Cancer Institute|2015Cited by 92
Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriersKaroline Kuchenbaecker, M. Durán, Susan L. Neuhausen et al.|Breast Cancer Research|2014Cited by 69
An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriersSophie Blein, Alan Donaldson, Claire Bardel et al.|Breast Cancer Research|2015Cited by 35
Candidate Genetic Modifiers for Breast and Ovarian Cancer Risk in <i>BRCA1</i> and <i>BRCA2</i> Mutation CarriersPaolo Peterlongo, Javier Benı́tez, Jenny Chang-Claude et al.|Cancer Epidemiology Biomarkers & Prevention|2014Cited by 25